Titan Pharmaceuticals Files 8-K
| Field | Detail |
|---|---|
| Company | Titan Pharmaceuticals Inc |
| Form Type | 8-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
TL;DR
Titan Pharma filed a routine 8-K, no major news.
AI Summary
Titan Pharmaceuticals, Inc. filed an 8-K on April 22, 2025, reporting other events and financial statements. The filing does not contain specific details about new events, dollar amounts, or significant changes beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Titan Pharmaceuticals is adhering to its reporting obligations with the SEC, but it does not disclose any new material events or financial updates.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain any new material information that would indicate increased risk.
Key Players & Entities
- Titan Pharmaceuticals, Inc. (company) — Registrant
- April 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-13341 (filing_number) — Commission File Number
- 94-3171940 (ein) — I.R.S. Employer Identification No.
FAQ
What is the purpose of this 8-K filing?
This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 22, 2025.
What is Titan Pharmaceuticals, Inc.'s state of incorporation?
Titan Pharmaceuticals, Inc. is incorporated in Delaware.
What is the Commission File Number for Titan Pharmaceuticals, Inc.?
The Commission File Number for Titan Pharmaceuticals, Inc. is 001-13341.
Does this filing disclose any specific new events or financial figures?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' but does not provide specific details on new events or financial figures within the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding TITAN PHARMACEUTICALS INC.